CPG
RPRX icon

Cornerstone Planning Group’s Royalty Pharma RPRX Stock Holding History

Cornerstone Planning Group’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.2K Buy
402
+106
+36% +$4.64K ﹤0.01% 663
2025
Q4 		$12K Sell
296
-235
-44% -$8.96K ﹤0.01% 748
2025
Q3 		$57.7K Buy
531
+406
+325% +$14.7K 0.01% 307
2025
Q2 		$4.74K Buy
125
+25
+25% +$828 ﹤0.01% 738
2025
Q1 		$3.17K Buy
100
+53
+113% +$1.68K ﹤0.01% 863
2024
Q4 		$1.49K Buy
+47
New +$1.25K ﹤0.01% 868

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Cornerstone Planning Group's RPRX Position: Q1 2026 in Review

Cornerstone Planning Group increased its Royalty Pharma (RPRX) stake by 36% in Q1 2026, buying an estimated $4.64K and bringing the position to 402 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Cornerstone Planning Group first reported a position in RPRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $57.7K in Q3 2025. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Cornerstone Planning Group held 402 shares of Royalty Pharma worth $20.2K as of Q1 2026.
  • Cornerstone Planning Group bought 106 Royalty Pharma shares in Q1 2026, an estimated $4.64K.
  • Royalty Pharma made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q1 2026, its #663 holding.
  • Cornerstone Planning Group first reported a position in Royalty Pharma in Q4 2024 and has held it in 6 quarters since.
  • Cornerstone Planning Group's Royalty Pharma position peaked at $57.7K in Q3 2025.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.